First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year...
Barchart Research What to Expect from CERS Earnings CERS Generated April 29, 2026 Current Price $1.9200 EPS Estimate $$-0.03 Consensus Rating Moderate Buy Average Move 8.18% Cerus Spent a Year Building...
Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System....
Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a...
William “Obi” Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026
/ARK%20Invest%20logo%20by%20ChrisStock82%20via%20Shutterstock.jpg)
Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.
2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial...
Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30...